Public Awareness and Attitude Regarding Adverse Drug Reactions: A Survey Among General Public in Southern India

Asian Journal of Pharmaceutical and Health Sciences,2021,10,4,2401-2407.
Published:March 2021
Type:Research Article
Author(s) affiliations:

Kaushik Shetty1, Sneha Sara John1, Noah M Bose*2

1Pharm.D intern, Department of Pharmacy Practice, Karavali College of Pharmacy, Mangalore.

2Assistant professor, Department of Pharmacy Practice, Karavali College of Pharmacy, Mangalore


Objectives: The study was undertaken to evaluate the perception and attitude of the general public towards adverse drug reactions.Methods: Study was carried out in the general public population using a questionnaire which included mostly open and few close-ended questions regarding attitude and awareness toward ADRs. Results: A total of 206 individuals responded to the questionnaire of which 114 were male and 92 were female. Maximum respondents were aged between 19 & 29 years (35%). Most of the respondents resided in urban areas. Around 45% of the respondents reported that they experienced adverse drug reactions after taking medications. Poor awareness about adverse drug reactions and its reporting process was found in the study. There was a positive attitude towards reporting adverse drug reactions and more than 86% of the respondents thought it was necessary to report adverse drug reactions. Almost all respondents agreed that if any easy method to report adverse drug reactions are available, they themselves can report the adverse drug reactions. Most of the individuals suggested that online reporting is an appropriate tool for adverse drug reaction reporting. Conclusion: The study observed a positive attitude among people towards adverse drug reactions reporting if an easy option is provided, though adverse drug reaction awareness showed a low trend. Imparting the general public with knowledge and awareness of adverse drug reaction & it’s reporting will bring a reporting culture among patients and increased adverse drug reaction reporting rates and thus help enhance the safety and monitoring of marketed medications.

Respondents demographic characteristics